See personalized New Product recommendations! Get personalized New Product recommendations! Register or Login for personalized New Product recommendations!
Holiday Notification: Cayman Chemical will be closed Monday, May 28, 2012, in observance of the Memorial Day holiday.
More…
Please feel free to continue placing orders via our website or via fax at 734-971-3640. You may send an email to customer service at custserv@caymanchem.com , or to technical support at techserv@caymanchem.com which we will respond to the next business day. Cayman will resume regular business hours and shipping schedules on Tuesday, May 29, 2012. Thank you for your patience and understanding.
Research Area · Allergy/Asthma
· See all 100+ product categories
| Item Number | Product | Sizes & Pricing | CAS | Purity | Image | Exclusive | Introduction Date | Mojo | Plain Text Name | Synonyms | Keywords | Interest |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 13510 |
11- |
37786-00-8 | ≥96% |
|
✓ | 70.517071823205 | 11-deoxy-prostaglandin-e1 | 11-deoxy PGE1 | 11-deoxy-PGE1 prostaglandins agonists analogs EP2 receptors | 70.517071823205 | ||
| 16520 |
11β- |
38432-87-0 | >99% |
|
40.775662983425 | 11-prostaglandin-f2 | 11β-PGF2α | 11.beta.-PGF2.alpha. 11beta-PGF2alpha metabolites PGD2 prostaglandins 9.beta.-11-deoxy-PGF2.alpha. 9beta-11-deoxy-PGF2alpha 9b-11-deoxy-PGF2alpha | 40.775662983425 | |||
| 516521 |
11β- |
- |
|
219.971497237568 | 11-prostaglandin-f2-eia-kit | 11β-Prostaglandin F2α ELISA Kit | solid plates metabolites mastocytosis 11beta-PGF2alpha prostaglandins measures kits eias enzyme immunoassays ELISAs 11.beta.-PGF2.alpha. 11b-PGF2alpha assays | 219.971497237568 | ||||
| 20150 |
14,15- |
114616-11-4 | >97% |
|
2008-06-02 | 41.183911602210 | 14-15-dehydro-leukotriene-b4 | 14,15-dehydro LTB4 | leukotrienes inflammation leukocytes antagonist LTB4 5-LO 5LO allergy asthma LTs inhibits inhibitors inhibition | 41.183911602210 | ||
| 10011360 |
14,15- |
75290-60-7 | >95% |
|
2008-05-23 | 42.751123388581 | 14-15-leukotriene-c4 | EXC4; Eoxin C4; 14,15-LTC4 | leukotrienes inflammation leukocytes 5-LO 15-LO 12-LO 5LO 15LO 12LO epoxytrienes asthma allergy pulmonary diseases eoxin inflammatory | 42.751123388581 | ||
| 10011362 |
14,15- |
1000852-57-2 | ≥97% |
|
2008-11-15 | 52.545722178374 | 14-15-leukotriene-e4 | 14,15-LTE4; EXE4; Eoxin E4 | leukotrienes inflammations leukocytes 5-LO 5LO 15LO 15-LO 12-LO 12LO epoxytrienes asthma allergy pulmonary disease eoxin cyslts cysteinyl leukotrienes | 52.545722178374 | ||
| 34720 |
15(S)- |
54845-95-3 | ≥98% |
|
36.312494080505 | 15-s-hete | soybean 15-LOs asthma airway 15-lipoxygenases monohydroxy fatty acids 15S-HETES 15-HETES arachidonic 15(S)-HETEs 15(S)HETEs potato polyunsaturated 15HETEs | 36.312494080505 | ||||
| 334720 |
15(S)- |
84807-87-4 | ≥99% deuterated forms (d1-d8) |
|
33.119594843463 | 15-s-hete-d8 | GC/MS deuterium isotopes 15-HETE-d8 standards 15S-HETE-d8 15(S)HETE-d8 deuterated GC-MS LC/MS LC-MS 15-HETEs 15(S)-HETEs 15S-HETEs 15(S)HETEs hydroxy fatty acids mass spectrometry 15HETE | 33.119594843463 | ||||
| 534721 |
15(S)- |
- |
|
73.321731123388 | 15-s-hete-eia-kit | 15(S)-HETE ELISA Kit | solid plates 15(S)-HETEs 15S-HETEs measures kits eias enzyme immunoassays ELISAs 15(S)HETEs 15HETEs assays | 73.321731123388 | ||||
| 10007251 |
15(S)- |
54845-95-3 | ≥98% |
|
2009-02-17 | 16.312885677858 | 15-s-hete-lipid-maps-ms-standard | soybean 15-LOs asthma airway 15-lipoxygenases monohydroxy fatty acids 15S-HETES 15-HETES arachidonic 15(S)-HETEs 15(S)HETEs potato polyunsaturated MS mass spectrometry standards 15HETE | 16.312885677858 | |||
| 60402 |
5- |
- | cell ly100,000 x g supernatant | 38.545455801104 | 5-lipoxygenase-human-recombinant | 5-LO; 5-LOX | 5-LOs enzymes 5-lipoxygenases atherosclerosis active | 38.545455801104 | ||||
| 10009638 |
5- |
- | 78 kDa (His-tagged), 74 kDa (native) | 2007-07-27 | 9.837928176795 | 5-lipoxygenase-human-recombinant-western-ready-control | 5-LOX; 5-LO | western blot WB 5(S)-HETE arachidonic acids leukotrienes rat basophilic leukemia alveolar eosinophils mast epithelial lungs blood | 9.837928176795 | |||
| 10007820 |
5- |
- | 2006-09-13 | 10.769070818684 | 5-lipoxygenase-phospho-ser523-polyclonal-antibody | 5-LO (Phospho-Ser523) Polyclonal Antibody | wb western blotting blots antibodies regulation leukotrienes asthma fibrosis atherosclerosis inflammation regulating phospho-specific immunoblotting | 10.769070818684 | ||||
| 10006618 |
5- |
- | 2005-03-07 | 0E-12 | 5-oxoete-receptor-blocking-peptide | TG1019; R527 | antibodies western blotting blots signaling signalling WB ICC immunocytochemistry 5-oxo-ETE receptors controls peptides proteins eicosatetraenoic acids PUFAs polyunsaturated fatty | 0E-12 | ||||
| 100025 |
5- |
- | 2004-12-14 | 255.799907918968 | 5-oxoete-receptor-polyclonal-antibody | TG1019; R527 | WB western blots blotting ICC immunocytochemistry 5-HETEs oxo-acids chemotactic chemotaxis 5-lipoxygenases 5-oxo-etes leukocytes PUFAs stimulators eosinophils neutrophils GPCR G-proteins coupled Gi/o cAMP cyclic inflammatory kidney liver receptors antibodies antisera antiserum 5oxoete immunoblotting | 255.799907918968 | ||||
| 10005032 |
5(S),6(R)- |
- | ≥95% |
|
2007-06-13 | 50.358149171270 | 5-s-6-r-7-trihydroxymethyl-heptanoate | BML-111 | lipoxins metabolites arachidonic acids AA lipoxygenases A4 LXA4 chemotaxis neutrophils PMN leukotrienes B4 LTB4 FMLP analogs inhibition plymorphonuclear | 50.358149171270 | ||
| 500840 |
Anti- |
- |
|
2012-02-14 | 46.808728740115 | anti-ovalbumin-ige-mouse-eia-kit | EIAs ELISAs enzymes immunoassays immunometric kits assays measures measurements immunizations mice mouse with chicken egg albumin OVA precipitate complexes aluminum hydroxides alum TH2-mediated immune immunity response OVA/alum immunized anti-OVA antibody antibodies IgG1 isotypes mediates tissues tissue-specific effectors models chronic inflammation allergy allergic asthma rhinitis cutaneous hypersensitivity levels plasma serum blood immunoglobulin OVA-specific plate-bound biotin-labeled monoclonal | 46.808728740115 | ||||
| 500830 |
Anti- |
- |
|
2011-11-21 | 81.754843281696 | anti-ovalbumin-igg1-mouse-eia-kit | EIAs enzymes immunoassays immunometric kits assays measures measurements eggs whites immunization mice mouse chickens albumin OVA precipitate complexes aluminum hydroxides alum TH2-mediated immune response immunity OVA/alum immunized anti-OVA antibodies IgG1 IgE isotypes mediate tissue-specific tissues effectors chronic inflammation allergic asthma rhinitis cutaneous hypersensitivity antibody plasma serum immunoglobulin OVA-specific TH2 | 81.754843281696 | ||||
| 10008640 | Asthma Treatment Standard Set | - |
|
2006-07-13 | 12.548692449355 | asthma-treatment-standard-set | CysLT1 receptors cysteinyl leukotrienes asthma allergy antagonists LTC4 LTD4 hypersensitivity oral peptidyl LTRA bronchoconstriction montelukast pranlukast zafirlukast zileuton 10006967 packs | 12.548692449355 | ||||
| 13160 |
AT- |
162640-98-4 | ≥95% |
|
✓ | 2010-06-22 | 6.983799877225 | at-56 | Prostaglandins D synthases L-PGDS PGD2 lipocalin-type inflammation inhibition inhibitors inhibits PGs eosinophils LPGDs bronchoalveolar lavage fluid Lysosomal Proton Translocating ATPases Vacuolar Proton-Translocating ATPases Vacuolar Membrane H(+)-ATPase Proteins Membrane-Associated Membrane-Associated Proteins Membrane Associated Proteins Tacrolimus Binding Proteins Proteins Rapamycin-Binding Proteins Integral Membrane Membrane Proteins Integral Binding Proteins Rapamycin Rapamycin-Binding Proteins Rapamycin Binding Proteins Protein Integral Membrane Integral Membrane Proteins Vacuolar F(1)F(0) ATPasesLysosomal F(1)F(0) ATPase Integral Membrane Protein Vacuolar F(1)F(0) ATPase Proteins Cell Membrane Protein FK-506-Binding Proteins Cell Surface Protein FK506-Binding FK-506-Binding ProteinFK506 Binding Proteins FK 506 Binding Protein Cell Membrane Proteins FK506-Binding ProteinFK506 Binding Protein Cell Surface Proteins H+-ATPase, Vacuolar Vacuolar H+-ATPase Vacuolar H+ ATPase Proteins Membrane Proteins Vacuolar ATPase Rotamase FKBP V Type ATPase FKBP Rotamase Membrane FKBP | 6.983799877225 | ||
| 10532 | BayCysLT2 Exclusive | 712313-33-2 | ≥95% |
|
✓ | 2010-09-22 | 2.552633517495 | baycyslt2 | CAY10633 | HAMI3379 cysLT2 receptors cardiovascular disease antagonists leukotrienes LTC4 LTD4 cysteinyl HAMI 3379 HAMI-3379 cyslts CAY10633 CAY-10633 CAY 10633 | 2.552633517495 | |
| 10156 |
BAY- |
116649-85-5 | >98% |
|
2004-11-17 | 19.377381215470 | bay-u3405 | Ramatroban | human medications allergic rhinitis antagonists thromboxanes TP receptors DP2/CRTH2 prostaglandins PGD2 7-transmembrane GPCRs G-protein-coupled BAYu3405 | 19.377381215470 | ||
| 10009599 | Calcipotriol (hydrate) | 112828-00-9 | ≥98% |
|
2008-02-08 | 84.621139758542 | calcipotriol-hydrate | Calcipotriene | vitamins D3 receptors calcium calcitriols JunB inflammations psoriasis skin irritations keratinocyte cells proliferations differentiations T immune response | 84.621139758542 | ||
| 10006735 | CAY10471 | 627865-18-3 | ≥98% |
|
2005-06-22 | 17.541892265193 | cay10471 | ramatroban DP2 CRTH2 antagonists TP receptors prostaglandins PGD2 7-transmembranes GPCRs G protein-coupled BAY-u3405 human medications allergic rhinitis analogs | 17.541892265193 | |||
| 13164 | CAY10589 Exclusive | 1077626-52-8 | ≥98% |
|
✓ | 2009-06-23 | 2.900145027624 | cay10589 | Microsomal prostaglandin E2 synthase-1 mPGES-1 inhibitors cyclooxygenase cyclooxygenase-2 COX-2 PGE2 5-lipoxygenase 5-LO COX-1 leukotrienes LTB4 LTC4 LTD4 LTE4 dual inhibits inhibition inflammation fever pain signaling sagnalling | 2.900145027624 | ||
| 13381 | CAY10606 | 1159576-98-3 | ≥98% |
|
2009-12-04 | 118.757262682069 | cay10606 | 5-lipoxygenases 5-LOs leukotrienes LTs LTB4 arachidonic acids inhibitors inhibit neutrophils blood ionophore A23187 formyl peptides fMLP lipopolysaccharides LPS reversed pleurisy inflammation inflammatory inhibition | 118.757262682069 | |||
| 9000549 | CAY10648 Exclusive | 916048-02-7 | ≥98% |
|
✓ | 2011-03-21 | 5.214737569060 | cay10648 | prostaglandins D2 PGD2 DP2 CRTH2 allergies inflammation antagonists intermediates tert-butyl 2-(5-chloro-2,2'-dioxospiro[indoline-3,3'-Pyrrolidine]-1-yl)acetate PGs | 5.214737569060 | ||
| 10804 | CAY10649 Exclusive | 1272519-89-7 | ≥98% |
|
✓ | 2011-04-04 | 16.559235727440 | cay10649 | 5-LO leukotrienes 5-lipoxygenases inhibitors inflammation smooth muscle contraction inhibition inhibited PMNL inflammatory | 16.559235727440 | ||
| 10743 | CAY10650 Exclusive | 1233706-88-1 | ≥98% |
|
✓ | 2011-06-14 | 12.111933701657 | cay10650 | cPLA2α cPLA2 inhibitors inflammation anti-inflammatory dermatitis metabolite phospholipase cytosolic prostaglandins PGs leukotrienes synthesis 10662 CAY-10650 CAY10641 CAY-10641 | 12.111933701657 | ||
| 10009852 |
CD4/CD8 Monoclonal FITC/PE Antibody (Clone RIV7/OKT- |
- | 2008-09-03 | 0.417248618784 | cd4-cd8-monoclonal-fitc-pe-antibody-clone-riv7-okt-8 | antibodies antisera antiserum FC flow cytometry human whole blood cells lysis white CD4-CD8 CD4+CD8 IF immunofluorescence | 0.417248618784 | |||||
| 13183 | CP 80633 | 135637-46-6 | ≥98% |
|
2010-05-20 | 10.566906077348 | cp-80633 | phosphodiesterases PDE cAMP cGMP asthma neurological diseases inhibitors inhibits inhibition PDE4 PDE1 PDE2 PDE3 PDE5 inflammation CP-80,633 CP-806333 CP80633 Pyrimidinones Pyrimidones | 10.566906077348 | |||
| 500390 | Cysteinyl Leukotriene EIA Kit | - |
|
2010-08-30 | 207.920448127686 | cysteinyl-leukotriene-eia-kit | CysLT ELISA Kit | cys LTs solid plates leukotrienes CysLTs acute inflammatory mediators arachidonic acids leukocytes 5-LO lipoxygenases bone marrow cells eosinophils mast macrophages LTA4 LTC4 LTD4 LTE4 human lungs mediators asthma hypersensitivity bronchoconstriction microvascular permeability vasoconstrictors coronary arteries competitive assays kits quantification urine culture media sample matrix matrices enzymes immuno ELISAs | 207.920448127686 | |||
| 10009291 | Cysteinyl Leukotriene Express EIA Kit | - |
|
2008-08-11 | 254.400657960824 | cysteinyl-leukotriene-express-eia-kit | CysLT Express ELISA Kit | solid plates leukotrienes CysLTs acute inflammatory mediators arachidonic acids leukocytes 5-LO lipoxygenases bone marrow cells eosinophils mast macrophages LTA4 LTC4 LTD4 LTE4 human lungs mediators asthma hypersensitivity bronchoconstriction microvascular permeability vasoconstrictors coronary arteries competitive assays kits quantification urine culture media sample matrix matrices enzymes immuno ELISAs | 254.400657960824 | |||
| 101640 | DP1 Receptor Polyclonal Antibody | - |
|
2004-10-22 | 22.917776243093 | dp1-receptor-polyclonal-antibody | Prostaglandin D2 Receptor 1; PGD2 Receptor 1 | isoforms prostaglandins PGs PGD2 cyclooxygenase metabolites G-protein coupled receptors GPCR cyclic cAMP Ca2+ calcium western blots blotting WB immunocytochemistry ICC immunohistochemistry IHC COX antibodies antiserum antisera atherosclerosis immunoblotting | 22.917776243093 | |||
| 10009549 | FABP4 (human recombinant) | - | ≥90% |
|
2007-06-15 | 16.343603909902 | fabp4-human-recombinant | A-FABP; ALBP; Adipocyte-FABP; Fatty Acid Binding Protein 4; aP2; Adipocyte Fatty Acid Binding Protein | cytosolic fatty acids lipophilic ligands tissues uptake metabolism intracellular trafficking lipid FABP-4 metabolic pathways cell growth differentiation bidirectional flux insulin epinephrine adipocytes atherosclerosis endocrinology | 16.343603909902 | ||
| 9001068 | FABP4 (human recombinant) FITC conjugated | - | ≥95% |
|
2011-08-23 | 6.631610102604 | fabp4-human-recombinant-fitc-conjugated | ALBP; Adipocyte-Fatty Acid Binding Protein; A-FABP; FABP4 | fatty acids adipocytes obesity insulin resistence sensitivity cardiovascular disease atherosclerosis inflammation FABP-4 | 6.631610102604 | ||
| 10010463 | FABP4 (human recombinant) Western Ready Control | - | 2007-10-23 | 3.441008287292 | fabp4-human-recombinant-western-ready-control | Fatty Acid Binding Protein 4; Adipocyte-FABP; ALBP; FABP4; A-FABP | fatty acids proteins western blots blotting WB binding proteins adipocytes atherosclerosis endocrinology immunoblotting | 3.441008287292 | ||||
| 10005191 | FABP4 (mouse recombinant) | - | ≥95% | 2005-07-27 | 6.236795580110 | fabp4-mouse-recombinant | Adipocyte-FABP; ALBP; Fatty Acid Binding Protein 4; A-FABP | protein-only protein-4 endogenous exogenous lipophilic ligands uptake metabolism intracellular trafficking lipid metabolic pathways modulation cell growth differentiation antiparallel .beta. strands barrel fat cells specific facilitate bidirectional flux insulin epinephrine proteins recombinant binding adipocytes fatty acids agonists insulin hyperinsulinemia deficiency afabp adipocytes atherosclerosis endocrinology | 6.236795580110 | |||
| 10009676 | FABP4 (mouse recombinant) Western Ready Control | - | 2007-04-30 | 2.515782688766 | fabp4-mouse-recombinant-western-ready-control | ALBP; Fatty Acid Binding Protein 4; Adipocyte-FABP; A-FABP | fatty acids proteins western blots blotting WB binding proteins adipocytes atherosclerosis | 2.515782688766 | ||||
| 10009162 | GW 627368X Exclusive | 439288-66-1 | ≥96% |
|
✓ | 2007-05-14 | 32.455359116022 | gw-627368x | EP4 receptor antagonist TP prostanoid prostaglandin platelets U-46619 aggregation PGE2 EP1 EP2 EP3 GW627368X GW-627368X | 32.455359116022 | ||
| 10580 | HAMI3379 Exclusive | 712313-35-4 | ≥90% |
|
✓ | 2011-03-14 | 89.886527229676 | hami3379 | cysLT2 receptors cardiovascular diseases antagonists leukotrienes LTC4 LTD4 cysteinyl LTs CysLTs perfusion pressure decrease contractility cyclohexanecarboxylic acids | 89.886527229676 | ||
| 10134 |
HQL- |
162641-16-9 | ≥98% |
|
155.543195211786 | hql-79 | inhibitors prostaglandins synthases PGD2 L-PGDS tetrazoles HQL79 inhibits lipocalin-type | 155.543195211786 | ||||
| 10888 | HZ52 | 1077626-51-7 | ≥98% |
|
2011-09-30 | 17.110718232043 | hz52 | inhibitors inhibits inhibition 5-LO 5 LO 5LO leukotrienes LTBs LTB4 LTs leukocytes neutrophils inflammation shock HZ-52 HZ 52 | 17.110718232043 | |||
| 10809 |
Interleukin- |
- |
|
2011-06-03 | 2.646408839779 | interleukin-33-human-monoclonal-antibody-clone-il33305b | IL-1F11; IL-33; NF-HEV | antibodies antiserum serum western blot WB immunoblotting ELISA enzyme-linked immunosorbent assay immunohistochemistry IHC immunoprecipitation IP IL 1F11 IL1F11 interleukin 33 NFHEV NF HEV | 2.646408839779 | |||
| 10811 |
Interleukin- |
- |
|
2011-06-02 | 1.323204419889 | interleukin-33-monoclonal-antibody-clone-il33026b | NF-HEV; IL-33; IL-1F11 | antibodies antiserum serum western blot WB immunoblotting ELISA enzyme-linked immunosorbent assay immunoprecipitation IP IL 1F11 IL1F11 interleukin 33 NFHEV NF HEV | 1.323204419889 | |||
| 10810 |
Interleukin- |
- |
|
2011-06-02 | 1.323204419889 | interleukin-33-monoclonal-antibody-clone-il333068a | IL-33; NF-HEV; IL-1F11 | antibodies antiserum serum western blot WB immunoblotting ELISA enzyme-linked immunosorbent assay 1F11 IL1F11 interleukin 33 NFHEV NF HEV | 1.323204419889 | |||
| 10011925 |
JNJ- |
459168-41-3 | ≥98% |
|
2011-02-24 | 0.482320441989 | jnj-7777120 | histamines H4 receptors antagonists inflammation Piperazines | 0.482320441989 | |||
| 10006198 |
Leukotriene C4- |
- | ≥99% deuterated forms (d1-d5) |
|
2007-04-11 | 154.699889502763 | leukotriene-c4-d5 | LTC4-d5 | cysteinyl-leukotrienes LTC4 asthma SRS-A slow-reacting substance anaphylaxis allergy peptido-leukotrienes cysteinyl-LTs peptido-LTs cys-LTs GC/MS deuterium isotopes LTC4-d5 internal standards deuterated LC/MS GC-MS LC-MS mass spectrometry | 154.699889502763 | ||
| 10007164 | Leukotriene C4 methyl ester | 73958-10-8 | >97% |
|
2005-11-23 | 56.971809392265 | leukotriene-c4-methyl-ester | LTC4 methyl ester | peptido-leukotrienes LTE4 asthma urine uninary allergy SRS-A slow-reacting substance anaphylaxis cysteinyl-LTs cysLTs peptido-LTs cys-LTs cysteinyl-leukotrienes fatty acids backbone dipeptidases plasma lipids soluble | 56.971809392265 | ||
| 10006199 |
Leukotriene D4- |
- | ≥99% deuterated forms (d1-d5) |
|
2008-04-23 | 52.451625887924 | leukotriene-d4-d5 | LTD4-d5 | peptido-leukotrienes LTD4 asthma urine uninary allergy SRS-A slow-reacting substance anaphylaxis cysteinyl-LTs peptido-LTs cys-LTs cysteinyl-leukotrienes deuterated deuterium cysLTs GC/MS GC-MS LC/MS LC-MS mass spectrometry | 52.451625887924 | ||
| 10007165 | Leukotriene D4 methyl ester | - | >97% |
|
2005-09-07 | 41.494419889502 | leukotriene-d4-methyl-ester | cysteinyl-LTs peptido-LTs cys-LTs cysteinyl-leukotrienes asthma SRS-A bronchoconstriction peptido-leukotrienes slow-reacting substance anaphylaxis allergy metabolites acute hypersensitivity vascular permeability | 41.494419889502 | |||
| 10007858 |
Leukotriene E4- |
- | ≥99% deuterated forms (d1-d5) |
|
2008-04-08 | 110.897298956415 | leukotriene-e4-d5 | LTE4-D5 | peptido-leukotrienes LTE4 asthma urine uninary allergy SRS-A slow-reacting substance anaphylaxis cysteinyl-LTs peptido-LTs cys-LTs cysteinyl-leukotrienes deuterated deuterium cysLTs GC/MS GC-MS LC/MS LC-MS mass spectrometry | 110.897298956415 | ||
| 10007166 | Leukotriene E4 methyl ester | - | >97% |
|
2005-10-25 | 41.979657458563 | leukotriene-e4-methyl-ester | peptido-leukotrienes LTD4 asthma urine uninary allergy SRS-A slow-reacting substance anaphylaxis cysteinyl-LTs peptido-LTs cys-LTs cysteinyl-leukotrienes fatty acids backbone dipeptidases plasma lipids soluble | 41.979657458563 | |||
| 390150 |
Linoleic Acid- |
79050-23-0 | ≥99% deuterated forms (d1-d4) |
|
✓ | 9.927914364641 | linoleic-acid-d4 | standards deuterated deuterium GC/MS internal isotopes GC-MS LC/MS LC-MS mass spectrometry fatty acids | 9.927914364641 | |||
| 10007577 | Luminex® Cysteinyl Leukotriene Kit | - |
|
2006-12-01 | 49.649348066298 | luminex-cysteinyl-leukotriene-kit | cys-LTs LTC4 LTD4 LTE4 measures kits asthma peptido-lts peptido-leukotrienes cysteinyl-leukotrienes allergy cysteinyl-LTs luminex xMAP beads kits assays | 49.649348066298 | ||||
| 500260 | Luminex® Leukotriene B4 Kit | - |
|
2008-11-12 | 61.059580110497 | luminex-leukotriene-b4-kit | Luminex® LTB4 Kit | leukotrienes arachidonic acids 5-lipoxygenases LTA4 hydrolases mediator inflammation leukocytes aggregation stimulation stimulates fluxes lysosomes lysosomal kits enzymes release superoxides anions production chemotaxis chemokinesis subnanomolar human neutrophils degranulation plasma hepatocytes 20-hydroxy 20-carboxy NADPH-dependent nicotinamides adenines dinucleotides phosphates CYP450 cytochromes b-oxidation .beta.-oxidation beta-oxidation w-end omega-end .omega.-end w-carboxy omega-carboxy .omega.-carboxy dinor tetranor urine culture media sample matrices EIAs ELISAs enzyme immunoassays assays | 61.059580110497 | |||
| 10007502 | Luminex® Thromboxane B2 Kit | - |
|
2009-07-13 | 37.424419889502 | luminex-thromboxane-b2-kit | Luminex® TXB2 Kit | thromboxanes thromboxane A2 TXA2 metabolites urine in vivo measures kits luminex xMAP beads assays | 37.424419889502 | |||
| 10008318 | Montelukast (sodium salt) | 151767-02-1 | ≥98% |
|
2006-04-20 | 30.970520915548 | montelukast-sodium-salt | Singulair® | cysteinyl-leukotrienes cysLT1 receptors antagonists LTC4 LTD4 mediators asthma hypersensitivity bronchoconstriction microvascular permeability vasoconstrictors coronary arteries protein-coupled GPCRs selective potent | 30.970520915548 | ||
| 13390 |
N- |
131391-65-6 | >97% |
|
2008-10-15 | 85.482108655616 | n-methyl-leukotriene-c4 | N-methyl LTC4 | allergy allergies asthma anaphylaxis SRS-A cysteinyl leukotrienes LTs mimetics | 85.482108655616 | ||
| 360900 |
PAF C- |
- | ≥99% deuterated forms (d1-d4) |
|
16.246022099448 | paf-c-16-d4 | Platelet-activating Factor C-16-d4 | PAFs deuterium GC/MS internal isotopes deuterated PAF-C-16-d4 standards GC-MS LC/MS LC-MS mass spectrometry platelet-activating factors atherosclerosis | 16.246022099448 | |||
| 13454 | PGDM New | 133161-96-3 | ≥90% (mixture) |
|
2012-02-02 | 35.393593482440 | pgdm | Prostaglandin D Metabolite | PGD-M urine PGD2 prostaglandins D2 PGs metabolites urinary side chains cyclization biomarkers endogenous allergic asthmatic sleep body temperatures (1R,2R,3S,5S)-2-[(2Z)-4-carboxy-2-buten-1-yl]-3,5-dihydroxy-γ-oxo-cyclopentanehexanoic acid | 35.393593482440 | ||
| 11344 |
PGDM- |
- | ≥99% deuterated forms (d1-d4) |
|
2012-02-02 | 35.913067166651 | pgdm-d4 | Prostaglandin D Metabolite-d4 | PGD-M deuterated deuterium GC/MS GC-MS LC/MS LC-MS mass spectrometry urine PGD2 prostaglandins D2 PGs metabolites urinary side chains cyclization biomarkers endogenous allergic asthmatic sleep body temperatures | 35.913067166651 | ||
| 10008319 | Pranlukast | 103177-37-3 | ≥98% |
|
2006-05-23 | 15.214056827150 | pranlukast | Ultair; ONO-1078 | CysLT1 receptors cysteinyl leukotrienes asthma allergy antagonists LTC4 LTD4 hypersensitivity oral peptidyl LTRA bronchoconstriction | 15.214056827150 | ||
| 12010 | Prostaglandin D2 | 41598-07-6 | ≥99% |
|
162.543959850903 | prostaglandin-d2 | PGD2 | Vasodilation prostaglandins brain sleep platelets aggregation. H-PGDS synthases mast cells hematopoietic allergic allergy asthmatic anaphylaxis hypotension inhibits inhibitors inhibition beta-trace .beta.-trace b-trace neurochemistry | 162.543959850903 | |||
| 10010123 |
Prostaglandin D2- |
- | ≥99% deuterated forms (d1-d9) |
|
2007-10-25 | 46.889442425124 | prostaglandin-d2-d9 | PGD2-d9 | GC/MS deuterium isotopes internal standards prostaglandins deuterated LC/MS GC-MS LC-MS mass spectrometry neurochemistry neuroscience allergy asthma | 46.889442425124 | ||
| 512031 | Prostaglandin D2 EIA Kit | - |
|
2010-07-19 | 203.609714548802 | prostaglandin-d2-eia-kit | PGD2 ELISA Kit | PGD2 prostaglandins measures kits eias enzyme immunoassays ELISAs measurements brains glutathione-independent lipocalin-type synthases L-PGDS cerebrospinal fluid CSF physiologic sleep rats humans mast cells leukocytes intracellular myeloid-type glutathione-dependent vascular 11β-PGF2α eicosanoids cultures lysates biosynthesis serum proteins albumin media medium methoximine derivatives PGD2-MOX competitive enzymatic reactions | 203.609714548802 | |||
| 512041 | Prostaglandin D2 Express EIA Kit | - |
|
2010-07-19 | 105.423217169570 | prostaglandin-d2-express-eia-kit | PGD2 Express ELISA Kit | PGD2 prostaglandins measures kits eias enzyme immunoassays ELISAs measurements brains glutathione-independent lipocalin-type synthases L-PGDS cerebrospinal fluid CSF physiologic sleep rats humans mast cells leukocytes intracellular myeloid-type glutathione-dependent vascular 11β-PGF2α eicosanoids cultures lysates biosynthesis serum proteins albumin media medium methoximine derivatives PGD2-MOX competitive enzymatic reactions | 105.423217169570 | |||
| 500581 |
Prostaglandin D2 FPIA Kit - |
- |
|
2004-11-16 | 48.428491022099 | prostaglandin-d2-fpia-kit-green | PGD2 Fluorescence Polarization Immunoassay - Green | PGD2 metabolites prostaglandins immunoassays HTS high-throughput kits screenings rapid measurements assays | 48.428491022099 | |||
| 512051 |
Prostaglandin D2 FPIA Kit - |
- |
|
2011-04-11 | 70.586690607734 | prostaglandin-d2-fpia-kit-red | PGD2 Fluorescence Polarization Immunoassay - Red | PGD2 Fluorescence Polarization Immunoassays metabolites prostaglandins D2 immunoassays HTS high-throughput kits screenings rapid measurements assays brains glutathione-independent lipocalin-type synthases L-PGDS cerebral spinal fluids CSF physiologic sleep rats humans mast cells leukocytes cellular myeloid-type glutathione-dependent hematopoietic H-PGDS intracellular vascular 11.beta.-PGF2.alpha. 11beta-PGF2alpha 11β-PGF2α β-oxidations beta-oxidations .beta.-oxidations tetranor-PGDM metabolites eicosanoids supernatants cultures enzymes preparations biosynthesis serum proteins albumin | 70.586690607734 | |||
| 10007202 | Prostaglandin D2 Lipid Maps MS Standard | 41598-07-6 | >99% | 2008-10-27 | 15.401542711432 | prostaglandin-d2-lipid-maps-ms-standard | PGD2 | Vasodilation prostaglandins brain sleep platelets aggregation. H-PGDS synthases mast cells hematopoietic allergic allergy asthmatic anaphylaxis hypotension inhibits inhibitors inhibition beta-trace .beta.-trace b-trace neurochemistry mass spectrometry standards GC LC MS | 15.401542711432 | |||
| 600007 |
Prostaglandin D Synthase (hematopoietic- |
- |
|
2009-01-21 | 60.508407835258 | prostaglandin-d-synthase-hematopoietic-type-fp-based-inhibitor-screening-assay-kit-green | H-PGDS FP-Based Inhibitor Screening Assay Kit - Green; Prostaglandin D Synthase (hematopoietic-type) Fluorescence Polarization-Based Inhibitor Screening Assay Kit - Green | assays kits measures measurements FPs fluorescent fluorescences polarizations polarization-based inhibitors inhibits inhibition prostaglandins synthases pgs H-PGDS PGD2 lipocalin-types L-PGDS allergies allergy allergic inflammatory inflammations reactions mast Th2 microglia necrotic muscles fibers apoptotic smooth HQL-79 tranilast guinea pigs lungs tissues pyrimidines amides amide-based single step fluoresceins probes Z' dynamic ranges mP units BSPTfluorescently-labeled HPGDS H-PGDS assays | 60.508407835258 | |||
| 10006593 |
Prostaglandin D Synthase (hematopoietic- |
- | ≥95% | 2005-02-16 | 27.636114180479 | prostaglandin-d-synthase-hematopoietic-type-human-recombinant | Hematopoietic-PGDS; H-PGDS; PGD Synthase (hematopoietic-type; human recombinant) | prostaglandins synthases PGDs PGD2 HPGDS H-PGDS enzymes peripheral tissues antigen-presenting cells mast megakaryocytes glutathiones glutathione-S-transferases allergen allergy allergic mediators active | 27.636114180479 | |||
| 10009625 |
Prostaglandin D Synthase (hematopoietic- |
- | 2007-07-19 | 21.429212707182 | prostaglandin-d-synthase-hematopoietic-type-human-recombinant-western-ready-control | Hematopoietic-PGDS; H-PGDS | western blot WB PGH2 lipocalin-type hematopoietic peripheral tisses antigen-presenting cells mast megakaryocytes allergic HPGDS H-PGDS inflammatory diseases inhibits inhibitor inhibition E. coli | 21.429212707182 | ||||
| 10004347 |
Prostaglandin D Synthase (hematopoietic- |
- | ≥85% | ✓ | 2008-06-05 | 33.375506445672 | prostaglandin-d-synthase-hematopoietic-type-mouse-recombinant | H-PGDS; Hematopoietic-PGDS | PGH2 lipocalin-type .beta.-trace prostaglandins hematopoietic enzymes PGD2 proteins recombinant inflammation activity high throughput screening inhibitors inhibits inhibition assays HPGDS H-PGDS active | 33.375506445672 | ||
| 10006595 | Prostaglandin D Synthase Inhibitor Screening Assay Kit | - |
|
2005-08-31 | 33.210460405156 | prostaglandin-d-synthase-inhibitor-screening-assay-kit | PGDS Inhibitor Screening Assay Kit | prostaglandins synthases inhibitors PGDS assays hematopoietic-types lipocalin-types pro-inflammatory mediators allergic allergy allergies allergens activity inhibitors inhibition inhibits H-PGDS L-PGDS | 33.210460405156 | |||
| 10006788 |
Prostaglandin D Synthase (lipocalin- |
- | ≥95% | 2005-03-23 | 38.766714022625 | prostaglandin-d-synthase-lipocalin-type-human-recombinant | L-PGDS; Lipocalin-PGDS | prostaglandins synthases PGDs PGD2 H-PGDS enzymes peripheral tissues antigen-presenting cells mast megakaryocytes glutathiones glutathione-S-transferases allergen allergy allergic mediators neurochemistry lpgds l-pgds active | 38.766714022625 | |||
| 10009741 | Prostaglandin D Synthase (lipocalin type; human) Western Ready Control | - | 2007-04-30 | 1.697615101289 | prostaglandin-d-synthase-lipocalin-type-human-western-ready-control | L-PGDS; Lipocalin-PGDS | GST lpgds l-pgds western blot WB neurochemistry hL-PGDS hLPGDS | 1.697615101289 | ||||
| 10006787 |
Prostaglandin D Synthase (lipocalin- |
- | ≥95% | 2005-03-23 | 42.061845953851 | prostaglandin-d-synthase-lipocalin-type-mouse-recombinant | L-PGDS; Lipocalin-PGDS | prostaglandins synthases PGDs PGD2 H-PGDS enzymes peripheral tissues antigen-presenting cells mast megakaryocytes glutathiones glutathione-S-transferases allergen allergy allergic mediators neurochemistry lpgds l-pgds active | 42.061845953851 | |||
| 10010548 |
Prostaglandin D Synthase (lipocalin- |
- | ≥95% | ✓ | 2008-07-01 | 40.950246493837 | prostaglandin-d-synthase-lipocalin-type-rat-recombinant | L-PGDS; Lipocalin-PGDS | prostaglandins PGH2 beta-trace b-trace proteins assays neurochemistry rL-PGDS rlPGDS .beta.-trace beta-trace b-trace recombinant human cerebrospinal fluid PGs CSF GST-tags GST-tagged N-terminal lpgds l-pgds active | 40.950246493837 | ||
| 13020 | Prostaglandin E1 Alcohol Exclusive | 21562-57-2 | >99% |
|
✓ | 25.600423572744 | prostaglandin-e1-alcohol | 1-hydroxy Prostaglandin E1; PGE1 Alcohol | PGE1 alcohols agonists prostaglandins EP2 EP4 receptors | 25.600423572744 | ||
| 13294 | Pyrrophenone | 341973-06-6 | ≥90% |
|
2010-04-07 | 48.304680347276 | pyrrophenone | phospholipase A2 group IVA phospholipase A2 PLA2 cytosolic PLA2 cPLA2 arachidonic acid AA prostaglandins PG leukotrienes LT inhibitors PGE2 LTB4 blood secretory type PLA2 sPLA2 inflammation inhibition inhibits inflammatory Pyrrolidines | 48.304680347276 | |||
| 10012554 | Resolvin D1 Exclusive | 872993-05-0 | ≥95% |
|
✓ | 2008-06-06 | 256.332392917195 | resolvin-d1 | RvD1; 17(S)-Resolvin D1 | EPA DHA inflammation antiinflammatory anti-inflammatory immune responses aspirin LOX peritonitis LOS neurochemistry resolvins 10007848 | 256.332392917195 | |
| 10011132 | Rolipram | 61413-54-5 | ≥98% |
|
2008-12-16 | 11.059300184162 | rolipram | ZK 62711; SB 95952 | inhibits inhibitor inhibition phosphodiesterase PDE4 cAMP inflammation leukocyte LPS TNF monocytes C5a LTC4 eosinophil neurons bones loss | 11.059300184162 | ||
| 13343 |
RSC- |
337307-06-9 | ≥95% |
|
2010-02-15 | 10.927624309392 | rsc-3388 | cytosolic phospholipases A2 cPLA2 cPLA2α arachidonic acids eicosanoids platelet-activating factors PAF inhibitors inhibits inhibition inflammation dermatitis acrylamides | 10.927624309392 | |||
| 13369 |
tetranor- |
52510-53-9 | ≥98% |
|
✓ | 2011-12-15 | 46.209071232465 | tetranor-pgam | tetranor-Prostaglandin A Metabolite | tetranor-PGEM PGE2 urine metabolites prostaglandins E2 biomarkers inflammation diseases therapeutic metabolism biosynthesis tetranor PGAM tetranorPGAM PGA-M PGE-M t-PGAM t-prostaglandin | 46.209071232465 | |
| 12850 |
tetranor- |
- | ≥90% |
|
✓ | 2008-04-08 | 56.499211662181 | tetranor-pgdm | tetranor-PGD Metabolite | metabolites urinary PGD2 prostaglandins D2 urine PGD-M t-PGDM t-prostaglandin | 56.499211662181 | |
| 10009039 |
tetranor- |
- | ≥99% deuterated product |
|
✓ | 2007-06-28 | 47.891203449603 | tetranor-pgdm-d6 | tetranor-Prostaglandin D Metabolite-d6 | deuterated deuterium GC/MS GC-MS LC/MS LC-MS mass spectrometry PGD-M t-PGDM t-prostaglandin | 47.891203449603 | |
| 13564 |
tetranor- |
- | ≥90% |
|
✓ | 2012-01-19 | 22.260990059556 | tetranor-pgdm-lactone | tetranor-Prostaglandin D Metabolite lactone | urine PGD2 prostaglandins D2 tetranor PGDM PGs allergic allergy asthma anaphylaxis sleep body temperature inhibits inhibition inhibitor platelets aggregation vascular smooth muscles urinary metabolites humans mouse biomarkers biosynthesis lactones PGD-M t-PGDM t-prostaglandin | 22.260990059556 | |
| 11213 |
tetranor- |
- | ≥99% deuterated forms (d1-d6) |
|
✓ | 2012-04-09 | 59.184893783723 | tetranor-pgdm-lactone-d6 | tetranor-Prostaglandin D Metabolite lactone-d6 | PGE-M deuterated deuterium GC/MS GC-MS LC/MS LC-MS mass spectrometry tetranor PGDM PGs allergic allergy asthma anaphylaxis sleep body temperature inhibits inhibition inhibitors platelets aggregation vascular smooth muscles urinary metabolites humans mouse biomarkers biosynthesis lactones PGD-M t-PGDM t-prostaglandins | 59.184893783723 | |
| 13363 |
tetranor- |
- | ≥98% |
|
✓ | 2011-12-15 | 45.829746224355 | tetranor-pgjm | tetranor-Prostaglandin J Metabolite | urine metabolites metabolism PGD2 prostaglandins D2 PGs tetranor-PGDM tetranor PGJM tetranorPGJM allergic allergies asthma anaphylaxis sleep temperature inhibits inhibition inhibitors platelets aggregation vascular smooth muscles urinary humans mouse mice biomarkers biosynthesis C-9 C9 C 9 PGJ-M PGJ-M t-PGJM t-prostaglandin | 45.829746224355 | |
| 11111 |
Toll- |
- | 2011-11-18 | 0.572551481667 | toll-like-receptor-10-monoclonal-antibody-clone-3c10c5 | TLR10; CD290 | TLRs innate immune systems transmembrane proteins cells patterns recognition receptors PRRs pathogen-associated molecular PAMPs signaling TIR domains Flow cytometry FC TLR10 TLR-10 | 0.572551481667 | ||||
| 10012559 | TP Receptor (human) Polyclonal FITC Antibody | - | 2008-07-25 | 56.391240024554 | tp-receptor-human-polyclonal-fitc-antibody | TXA2 Receptor; Thromboxane A2 Receptor | antibodies antiserum antisera thromboxane A2 TXA2 receptors flow cytometry FC IF immunofluorescence western blots blotting WB immunoblotting | 56.391240024554 | ||||
| 13044 | Tranilast | 53902-12-8 | ≥98% |
|
2008-08-29 | 71.116731123388 | tranilast | SB 252218; Rizaben; MK 341; Tranpro; N-(3',4'-Dimethyoxycinnamoyl)Anthranilic Acid | anti-inflammatory antiinflammatory angiogenesis PGDF TGF-.beta.1 TGF.beta.1 IL-8 IL8 PGE2 TXB2 antiallergenic anti-allergenic atherosclerosis vascular disease VEGF | 71.116731123388 | ||
| 10010519 | Vialinin A | 858134-23-3 | ≥98% |
|
2008-07-25 | 30.670589318599 | vialinin-a | Terrestrin A | .beta.-hexosaminidase b-hexosaminidase beta-hexosaminidase TNF-.alpha. TNF-a TNF-alpha IL-4 IL4 CCL2 MCP-1 MCP1 antiallergic anti-allergic anti-inflammatory antiinflammatory RBL-2H3 cells RBL2H3 mast antioxidant | 30.670589318599 | ||
| 13246 |
YM- |
223499-30-7 | ≥98% |
|
2009-11-16 | 5.369171270719 | ym-58483 | BTP 2 | calcium channels leukocytes leukotrienes eicosanoids inflammation asthma allergy IL-2 IL-4 lymphocytes eosinophils NF-AT CRACs CysLTs interleukin-4 BTP2 BTP-2 CysLT | 5.369171270719 | ||
| 13665 | YS121 Exclusive | 916482-17-2 | ≥98% |
|
✓ | 2010-04-02 | 17.990220994475 | ys121 | Microsomal Prostaglandin E2 Synthase-1 mPGES-1 cyclooxygenase-2 COX-2 PGE2 inflammation fever pain 5-Lipoxygenase 5-LO leukotrienes LTs inhibitors LTB4 cyclooxygenase-1 COX-1 LTC4 LTD4 LTE4 inhibition Pyrimidines inhibits PGs YS 121 YS-121 | 17.990220994475 | ||
| 10008282 | Zafirlukast | 107753-78-6 | ≥97% |
|
2006-05-01 | 18.503117600631 | zafirlukast | Accolate® | cysteinyl-leukotrienes cysLT1 receptors GPCRs protein-coupled antagonists asthma asthmatic allergies allergic rhinitis selective cysLTs cys-LTs cys-LT1 accolate™ | 18.503117600631 | ||
| 10006967 | Zileuton | 111406-87-2 | >98% |
|
2005-09-09 | 20.302014949626 | zileuton | Zyflo® | cysteinyl-leukotrienes CysLTs LTC4 LTD4 LTE4 pathophysiology asthma arachidonic acids fatty 5-LO 5-lipoxygenases pathway inhibitors inhibition inhibits prevention treatment RBL-1 cells LTB4 production purified human peripheral blood PMNL | 20.302014949626 |
Cayman Chemical Company · 1180 East Ellsworth Road · Ann Arbor, Michigan 48108 · USA
Toll Free: (800) 364-9897 (USA and Canada Only) · Fax: (734) 971-3640
Copyright 2012 Cayman Chemical Company
Quick Search